Table 1 Patient characteristics
Patient, no. | Age [years] | PSA [μg/L] | PSA doubling time [months] | Indication Gleason | Activity [MBq] | Activity/weight [MBq/kg] | Local PSMA+ | Nodal PSMA+ | Distant PSMA+ | Therapeutic consequence |
|---|---|---|---|---|---|---|---|---|---|---|
1 | 76 | 1.48 ADT | 8 | RT, ADT. Intensification of the ADT? 4 + 4 | 363 | 4.78 | Right prostate | 0 | Sternum | RT prostate. No intensification of the ADT |
2 | 67 | 0.7 | 9 | BCR after prostatectomy 4 + 3 | 355 | 4.03 | 0 | 2 LNs left iliacal | 0 | RT LNs |
3 | 66 | 1.03 | > 12 | BCR after prostatectomy and RT 4 + 3 | 347 | 3.62 | 0 | 0 | 0 | Wait and see |
4 | 74 | 1.1 | 4 | BCR after prostatectomy 3 + 4 | 350 | 4.73 | 0 | 1 LN left iliacal | 0 | S-LAD and RT LN |
5 | 63 | 4.7 | n.a. | BCR after prostatectomy. 4 + 3 | 329 | 3.78 | Right prostate | 0 | 0 | RT prostate fossa |
6 | 64 | 130.0 ADT | 3 | Prostatectomy, ADT. Planning local intervention? n.a. | 384 | 3.96 | Right prostate | 2 LNs pre-sacral 1 LN right iliacal | > 5 osseous lesions | No cystectomy |
7 | 52 | 14.9 | > 12 | BCR after prostatectomy and RT 3 + 3 | 370 | 4.30 | 0 | 0 | 0 | Wait and see |
8 | 73 | 0.8 | 5 | BCR after prostatectomy 4 + 3 | 371 | 4.95 | 0 | 3 LNs retroperitoneal | 0 | RT LNs |
9 | 74 | 1.02 | > 12 | BCR after prostatectomy 3 + 4 | 379 | 4.6 | 0 | 0 | 0 | Wait and see |
10 | 59 | 0.51 | n.a. | BCR after prostatectomy 4 + 3 | 345 | 3.45 | 0 | 0 | 0 | RT prostate fossa |